| Corticosteroids, but not TNF antagonists, are associated with adverse COVID-19 outcomes in patients with inflammatory bowel diseases: results from an international registry EJ Brenner, RC Ungaro, RB Gearry, GG Kaplan, M Kissous-Hunt, ... Gastroenterology 159 (2), 481-491. e3, 2020 | 733 | 2020 |
| Single-cell analysis of Crohn’s disease lesions identifies a pathogenic cellular module associated with resistance to anti-TNF therapy JC Martin, C Chang, G Boschetti, R Ungaro, M Giri, JA Grout, K Gettler, ... Cell 178 (6), 1493-1508. e20, 2019 | 620 | 2019 |
| Antibiotics associated with increased risk of new-onset Crohn’s disease but not ulcerative colitis: a meta-analysis R Ungaro, CN Bernstein, R Gearry, A Hviid, KL Kolho, MP Kronman, ... Official journal of the American College of Gastroenterology| ACG 109 (11 …, 2014 | 481 | 2014 |
| Effect of IBD medications on COVID-19 outcomes: results from an international registry RC Ungaro, EJ Brenner, RB Gearry, GG Kaplan, M Kissous-Hunt, ... Gut 70 (4), 725-732, 2021 | 297 | 2021 |
| A treat-to-target update in ulcerative colitis: a systematic review R Ungaro, JF Colombel, T Lissoos, L Peyrin-Biroulet Official journal of the American College of Gastroenterology| ACG 114 (6 …, 2019 | 239 | 2019 |
| Constitutive activation of epithelial TLR4 augments inflammatory responses to mucosal injury and drives colitis-associated tumorigenesis M Fukata, L Shang, R Santaolalla, J Sotolongo, C Pastorini, C España, ... Inflammatory bowel diseases 17 (7), 1464-1473, 2011 | 237 | 2011 |
| Management of patients with Crohn’s disease and ulcerative colitis during the coronavirus disease-2019 pandemic: results of an international meeting DT Rubin, MT Abreu, V Rai, CA Siegel, V Ahuja, M Allez, ... Gastroenterology 159 (1), 6-13. e6, 2020 | 236 | 2020 |
| A novel Toll-like receptor 4 antagonist antibody ameliorates inflammation but impairs mucosal healing in murine colitis R Ungaro, M Fukata, D Hsu, Y Hernandez, K Breglio, A Chen, R Xu, ... American Journal of Physiology-Gastrointestinal and Liver Physiology 296 (6 …, 2009 | 191 | 2009 |
| Deep remission at 1 year prevents progression of early Crohn’s disease RC Ungaro, C Yzet, P Bossuyt, FJ Baert, T Vanasek, GR D’Haens, ... Gastroenterology 159 (1), 139-147, 2020 | 168 | 2020 |
| The role of early biologic therapy in inflammatory bowel disease DR Berg, JF Colombel, R Ungaro Inflammatory bowel diseases 25 (12), 1896-1905, 2019 | 166 | 2019 |
| Gut microbiota density influences host physiology and is shaped by host and microbial factors EJ Contijoch, GJ Britton, C Yang, I Mogno, Z Li, R Ng, SR Llewellyn, ... Elife 8, e40553, 2019 | 166 | 2019 |
| Prevalence of migraine in patients with celiac disease and inflammatory bowel disease AK Dimitrova, RC Ungaro, B Lebwohl, SK Lewis, CA Tennyson, ... Headache: The Journal of Head and Face Pain 53 (2), 344-355, 2013 | 150 | 2013 |
| predictors of response to vedolizumab and ustekinumab in inflammatory bowel disease A Barré, JF Colombel, R Ungaro Alimentary pharmacology & therapeutics 47 (7), 896-905, 2018 | 136 | 2018 |
| Intestinal inflammation modulates the expression of ACE2 and TMPRSS2 and potentially overlaps with the pathogenesis of SARS-CoV-2–related disease M Suárez-Fariñas, M Tokuyama, G Wei, R Huang, A Livanos, D Jha, ... Gastroenterology 160 (1), 287-301. e20, 2021 | 133 | 2021 |
| Approach to the management of recently diagnosed inflammatory bowel disease patients: a user’s guide for adult and pediatric gastroenterologists M Agrawal, EA Spencer, JF Colombel, RC Ungaro Gastroenterology 161 (1), 47-65, 2021 | 131 | 2021 |
| Association between tumor necrosis factor inhibitors and the risk of hospitalization or death among patients with immune-mediated inflammatory disease and COVID-19 Z Izadi, EJ Brenner, SK Mahil, N Dand, ZZN Yiu, M Yates, RC Ungaro, ... JAMA network open 4 (10), e2129639-e2129639, 2021 | 115 | 2021 |
| Presenting symptoms in inflammatory bowel disease: descriptive analysis of a community-based inception cohort BK Perler, R Ungaro, G Baird, M Mallette, R Bright, S Shah, J Shapiro, ... BMC gastroenterology 19, 1-8, 2019 | 115 | 2019 |
| What should gastroenterologists and patients know about COVID-19? RC Ungaro, T Sullivan, JF Colombel, G Patel Clinical Gastroenterology and Hepatology 18 (7), 1409-1411, 2020 | 113 | 2020 |
| Microbiota regulate the ability of lung dendritic cells to induce IgA class-switch recombination and generate protective gastrointestinal immune responses D Ruane, A Chorny, H Lee, J Faith, G Pandey, M Shan, N Simchoni, ... Journal of Experimental Medicine 213 (1), 53-73, 2016 | 108 | 2016 |
| Toll-like receptor 4 differentially regulates epidermal growth factor-related growth factors in response to intestinal mucosal injury D Hsu, M Fukata, YG Hernandez, JP Sotolongo, T Goo, J Maki, LA Hayes, ... Laboratory investigation 90 (9), 1295-1305, 2010 | 98 | 2010 |
